1
Lipolysis SupportWeak
This is the entire case for AOD-9604. It remains more plausible than proven.
4.5/10
Weak
AOD-9604
AOD-9604 · GH fragment · Metabolic / Fat loss
The fat-loss peptide with a clean idea and a much less convincing scoreboard. Interesting design, weak payoff, and no reason to confuse it with real obesity medicine. More concept than category leader.
Cost / mo
$90–140
Forms
SubQ
Onset
3–6 weeks
Cycle
8–12 weeks
Studies
10+
Should you care about AOD-9604?
You should care only if you're specifically evaluating speculative fat-loss adjuncts and want to know where the floor really is. AOD-9604 isn't nonsense. It's just not compelling enough to escape the speculative bin.
The core issue is that commercial enthusiasm outlived commercial success. If the human signal had been strong enough, this would not still be living on peptide-site nostalgia.
What the internet says
"AOD-9604 is fat-loss support without the downsides of real metabolic drugs."
What the data says
Maybe fewer systemic tradeoffs, but also much less convincing efficacy. A cleaner weak signal is still a weak signal.
What it actually does (ranked by evidence)
2
Adjunct Body-Composition SupportWeak
Potentially useful as a sidecar inside a stronger plan, which is a polite way of saying not convincing enough to lead one.
3
Endocrine-Sparing DesignWeak
Good concept. Still secondary to the question of whether the actual outcomes justify paying attention.
Dosing
Speculative fat-loss tools deserve the same skepticism as any other speculative fat-loss tool, even when the mechanism sounds neat.
Oral
No standard oral form
AOD-9604 is generally used by injection. If convenience is the pitch, you're already looking at the wrong compound.
Injectable
250–500 mcg/day
Usually run daily, often fasted, and still rarely backed by outcome data that justify dramatic expectations.
If a stronger metabolic tool is already available, this usually ends up as a curiosity rather than a cornerstone.
Side effects: the honest version
✓ Confirmed safe
- ✓Injection-site irritation
- ✓Mild headache
- ✓Occasional nausea
! Unknown
- iLimited efficacy may be a bigger issue than side effects for many users.
- iFat-loss claims should be treated cautiously unless the rest of the metabolic protocol is already strong.
- iThe compound's market presence exceeds its evidence strength.
The studies that matter
We read all 10+. These are the three we'd cite first.
AOD-9604 in obesity-development programs
WeakMetabolic and obesity literature · 2000s
Result: Some positive body-composition signal, not enough to become a breakout therapy
GH-fragment lipolysis mechanistic work
WeakPreclinical metabolic studies · 2000s–2010s
Result: Mechanism stayed interesting even when the commercial case softened
Follow-on human interest in AOD-9604 fat-loss protocols
WeakSmall clinic and translational reports · 2010s–2020s
Result: Enough anecdotal persistence to keep it alive, not enough proof to move it up a tier
How it stacks up
Metabolic peptide comparison. No hedging.
Score
4.5
9.1
9.4
Evidence
Weak
Strong
Strong
Oral?
No
Yes ✓
No
Cost / mo
$90–140
$300–1,200
$500–1,300
Best for
Body-fat reduction support
Real weight loss
Maximum efficacy
Our pick?
Situational
Yes ★
If tolerated
What the internet says
"Because it's an HGH fragment, it's basically a smarter semaglutide alternative."
What the data says
No. Different biology, different evidence depth, and nowhere near the clinical outcome profile of GLP-1 or GIP/GLP-1 therapies.
Questions people actually ask
Answers that don't insult your intelligence.
No. It is a fragment designed to capture one proposed part of growth-hormone biology, not the full hormone.
★ Bottom Line
AOD-9604 is the kind of compound people want to love because the concept is tidy. The problem is that the concept still outperforms the outcome data.
— PepTalk Editorial Team · March 2026